Steve Byrne's questions to Bioceres Crop Solutions (BIOX) leadership • Q3 2025
Question
Steve Byrne requested field trial data for the Neovo corn product in the U.S., its yield impact versus conventional chemicals, and the go-to-market partnership strategy. He also asked about interest from U.S. and Canadian seed companies for HB4 traits.
Answer
CCO Milen Marinov stated that while specific data couldn't be shared, Neovo has five years of trials showing results equivalent to the leading standard, with over 120 replicated field trials currently underway in the U.S. The company is pursuing a dual strategy with both strategic and channel partners. CEO Federico Trucco added that they are advancing with partners for HB4 wheat in the U.S. Midwest, but HB4 soy commercialization in the U.S. and Canada remains a longer-term prospect of 2-3 years or more.